Kaouthar Lbiati - Feb 19, 2024 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

Role
Director
Signature
/s/ Kaouthar Lbiati
Stock symbol
HEPA
Transactions as of
Feb 19, 2024
Transactions value $
$0
Form type
4
Date filed
2/21/2024, 08:01 PM
Previous filing
Jul 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HEPA Stock Options Award $0 +85K +2833.33% $0.00 88K Feb 19, 2024 Common Stock 85K $2.56 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.